These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 3917454

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Growth hormone secretion in anaesthetized fowl. 2. Influence of heterologous stimuli in birds refractory to human pancreatic growth hormone-releasing (hpGRF) or thyrotrophin releasing hormone (TRH).
    Scanes CG, Harvey S.
    Gen Comp Endocrinol; 1985 Jul; 59(1):10-4. PubMed ID: 3926600
    [Abstract] [Full Text] [Related]

  • 43. Acromegaly due to ectopic growth hormone (GH)-releasing hormone (GHRH) production: dynamic studies of GH and ectopic GHRH secretion.
    Barkan AL, Shenker Y, Grekin RJ, Vale WW, Lloyd RV, Beals TF.
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1057-64. PubMed ID: 3093517
    [Abstract] [Full Text] [Related]

  • 44. Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly.
    Arafah BM, Rosenzweig JL, Fenstermaker R, Salazar R, McBride CE, Selman W.
    J Lab Clin Med; 1987 Mar; 109(3):346-54. PubMed ID: 3102658
    [Abstract] [Full Text] [Related]

  • 45. Bromocriptine therapy in acromegaly: use in patients resistant to conventional therapy and effect on serum levels of somatomedin C.
    Moses AC, Molitch ME, Sawin CT, Jackson IM, Biller BJ, Furlanetto R, Reichlin S.
    J Clin Endocrinol Metab; 1981 Oct; 53(4):752-8. PubMed ID: 6793607
    [Abstract] [Full Text] [Related]

  • 46. Growth hormone response to thyrotropin-releasing hormone in the urethane-anesthetized rat: effect of thyroid status.
    Szabo M, Ruestow PC, Kramer DE.
    Endocrinology; 1985 Jul; 117(1):330-7. PubMed ID: 3924582
    [Abstract] [Full Text] [Related]

  • 47. Thyrotropin-releasing hormone increases serum levels of growth hormone-releasing hormone and growth hormone in patients with acromegaly.
    Hulting AL, Theodorsson E, Werner S.
    J Intern Med; 1992 Sep; 232(3):229-35. PubMed ID: 1402619
    [Abstract] [Full Text] [Related]

  • 48. Growth hormone responses to oral glucose loading measured by highly sensitive enzyme immunoassay in normal subjects and patients with glucose intolerance and acromegaly.
    Hattori N, Shimatsu A, Kato Y, Koshiyama H, Ishikawa Y, Assadian H, Tanoh T, Nagao M, Imura H.
    J Clin Endocrinol Metab; 1990 Mar; 70(3):771-6. PubMed ID: 2106529
    [Abstract] [Full Text] [Related]

  • 49. Abnormal growth hormone responses to CB-154 and thyrotropin-releasing hormone (TRH) in patients with acromegaly.
    Hanew K, Aida M, Sasaki A, Mouri T, Yoshinaga K.
    Tohoku J Exp Med; 1979 Jan; 127(1):53-62. PubMed ID: 104407
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. The effect of minisomatostatin on anomalous growth hormone responses in acromegaly.
    Pieters GF, Smals AE, Smals AG, von Gennep JA, Kloppenborg PW.
    Acta Endocrinol (Copenh); 1987 Apr; 114(4):537-42. PubMed ID: 2883797
    [Abstract] [Full Text] [Related]

  • 52. Age-related changes in plasma growth hormone response to growth hormone-releasing factor in man.
    Shibasaki T, Shizume K, Nakahara M, Masuda A, Jibiki K, Demura H, Wakabayashi I, Ling N.
    J Clin Endocrinol Metab; 1984 Jan; 58(1):212-4. PubMed ID: 6417155
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Growth hormone (GH)-releasing activity of TRH and GH-lowering effect of dopaminergic drugs in acromegaly: homogeneity in the two responses.
    Liuzzi A, Chiodini PG, Botalla L, Silvestrini F, Müller EE.
    J Clin Endocrinol Metab; 1974 Nov; 39(5):871-6. PubMed ID: 4214404
    [No Abstract] [Full Text] [Related]

  • 56. Plasma growth hormone responses to repetitive administrations of growth hormone releasing factor in patients with pituitary dwarfism.
    Hizuka N, Takano K, Shizume K, Hirose N, Ling NC.
    Endocrinol Jpn; 1984 Dec; 31(6):697-704. PubMed ID: 6442698
    [Abstract] [Full Text] [Related]

  • 57. Clinical use of pre- and postsurgical evaluation of abnormal GH responses in acromegaly.
    Arosio M, Giovanelli MA, Riva E, Nava C, Ambrosi B, Faglia G.
    J Neurosurg; 1983 Sep; 59(3):402-8. PubMed ID: 6411870
    [Abstract] [Full Text] [Related]

  • 58. Characterization of serum growth hormone (GH) and insulin-like growth factor I in active acromegaly with minimal elevation of serum GH.
    Daughaday WH, Starkey RH, Saltman S, Gavin JR, Mills-Dunlap B, Heath-Monnig E.
    J Clin Endocrinol Metab; 1987 Oct; 65(4):617-23. PubMed ID: 3654910
    [Abstract] [Full Text] [Related]

  • 59. Acute effects of a single administration of dexamethasone on basal and growth hormone-releasing hormone stimulated GH secretion in acromegaly.
    Losa M, Arosio M, Cusin A, Biella O, Palmieri E, Faglia G, Giovanelli M.
    Clin Endocrinol (Oxf); 1994 Feb; 40(2):187-91. PubMed ID: 8137516
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.